MUN64026
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 408050

CAS#: 2291164-02-6

Description: MUN64026 is IDO1 inhibitor. MUN64026 was first reported in Gilead's patent: WO 2019040102. MUN64026 has CAS#2291164-02-6. There is no formal name for compound. For the convenience of scientific communication, we named it as MUN64026 based on Hodoodo Chemical Nomenclature proposed by MedKoo.


Price and Availability

Size
Price

Size
Price

Size
Price

MUN64026, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 408050
Name: MUN64026
CAS#: 2291164-02-6
Chemical Formula: C26H17F3N4O
Exact Mass: 458.1354
Molecular Weight: 458.4442
Elemental Analysis: C, 68.12; H, 3.74; F, 12.43; N, 12.22; O, 3.49


Synonym: MUN64026; MUN-64026; MUN 64026;

IUPAC/Chemical Name: 5-(3-(2,3-difluorophenyl)imidazo[1,5-a]pyridin-8-yl)-N-(4-fluorophenyl)-2-methylnicotinamide

InChi Key: MBXPCHYYQRPOOA-UHFFFAOYSA-N

InChi Code: InChI=1S/C26H17F3N4O/c1-15-21(26(34)32-18-9-7-17(27)8-10-18)12-16(13-30-15)19-5-3-11-33-23(19)14-31-25(33)20-4-2-6-22(28)24(20)29/h2-14H,1H3,(H,32,34)

SMILES Code: O=C(C1=CC(C2=CC=CN3C2=CN=C3C4=CC=CC(F)=C4F)=CN=C1C)NC5=CC=C(F)C=C5


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
2934.99.90.01


References

1. Bartlett, Mark J.; Corkey, Britton Kenneth; Cosman, Jennifer Leigh; Elbel, Kristyna M.; Elzein, Eifatih; Kalla, Rao V.; Koltun, Dmitry; Li, Xiaofen; Parkhill, Eric Q.; Perry, ThaoPreparation of therapeutic heterocyclic compounds as IDO1 inhibitors. PCT Int. Appl. (2019), WO 2019040102 A1 20190228.